Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
52,388
Sort by:
Global In-Vitro Diagnostics Market
US$ 3,475.00
Global In-vitr-diagnostics (IVD) Market By Offerings (Reagents, Instruments, and Software And Services), By Technology (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinic...
October 2024
169 pages
Global Lung Cancer Therapy Market: Analysis By Treatment Method (Non-Invasive and Minimally Invasive), By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, and Other Therapies), By Indication (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Carcinoid), By End-User (Hospitals, Oncology Clinics, Research Centers, and Others), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,450.00
The global lung cancer therapy market was valued at US$32.50 billion in 2023. The market value is expected to reach US$70.39 billion by 2029. Lung cancer therapy is a critical area of oncology, focusi...
September 2024
184 pages
Hemophilia A Treatment Market - 2024-2031
US$ 3,400.00
Hemophilia A Treatment Market reached US$ 9.1 billion in 2022 and is expected to reach US$ 13.3 billion by 2031, growing with a CAGR of 5.00% during the forecast period 2026-2031. The Hemophilia A Tre...
September 2024
48 pages
Sepsis Diagnostic Market - 2024-2031
US$ 3,400.00
Sepsis Diagnostic Marketis is growing with a CAGR of 9.50% during the forecast period 2026-2035. The Sepsis Diagnostic Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
September 2024
43 pages
Urinalysis Market - 2024-2031
US$ 3,400.00
Urinalysis Marketis is growing with a CAGR of 6.90% during the forecast period 2026-2035. The Urinalysis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned re...
September 2024
36 pages
Predictive Diagnostics Market - 2024-2031
US$ 3,400.00
Predictive Diagnostics Marketis is growing with a CAGR of 14.70% during the forecast period 2026-2035. The Predictive Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth a...
September 2024
49 pages
